Literature DB >> 32160160

Quercetin modulates granulosa cell mRNA androgen receptor gene expression in dehydroepiandrosterone-induced polycystic ovary in Wistar rats via metabolic and hormonal pathways.

Olugbemi T Olaniyan1, Okoli Bamidele2, Charles O Adetunji3, Bretet Priscilla4, Adebayo Femi4, Dare Ayobami4, Gloria Okotie5, Ibitoye Oluwaseun6, Eweoya Olugbenga7, Pratap C Mali8.   

Abstract

Background It is estimated that about 5-10% of women suffer from polycystic ovarian syndrome (PCOS) which is a major cause of female reproductive dysfunction. This study examined the role of quercetin on dehydroepiandrosterone (DHEA)-induced PCO in Wistar rats. Methods Twenty-eight pre-pubertal female Wistar rats that are 21 days old weighing 16-21 g were sorted into four groups (n = 7). Group I served as control and was given distilled water only, Group II were injected with 6 mg/100 g BW of DHEA in 0.2 mL of corn oil subcutaneously, Group III received 100 mg/kg BW of quercetin orally and Group IV received 6 mg/100 g BW of DHEA in 0.2 mL of corn oil subcutaneously and 100 mg/kg BW of quercetin orally. Rats were sacrificed after 15 days by cervical dislocation method. Blood samples and ovaries were collected for hormonal, biochemical, and histopathological analysis and expressions of mRNA androgen receptor gene were determined using RT-qPCR. All data were analysed using one-way ANOVA. Results A significant decrease (p < 0.05) in the antioxidant and metabolic enzyme activity in the DHEA treated group was observed when compared with control. DHEA co-administration with quercetin showed a significant decrease in malondialdehyde and cytokines when compared with DHEA treated group. Also a significant increase in progesterone, metabolic and antioxidant enzyme activity was observed. The histopathology demonstrates a reduction in cystic and atretic cells, improved expression of BCl2, E-Cadherin and a decrease in Bax. Conclusions Quercetin alleviated DHEA-induced PCO. These effects could be attributed to its antioxidant property.

Entities:  

Keywords:  PCOS; Wistar rats; dehydroepiandrosterone; mRNA androgen receptor; quercetin

Mesh:

Substances:

Year:  2020        PMID: 32160160     DOI: 10.1515/jbcpp-2019-0076

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  3 in total

1.  Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis.

Authors:  Zhi Zeng; Xia Lin; Tingting Xia; Wenxiu Liu; Xiaohui Tian; Manchao Li
Journal:  Biomed Res Int       Date:  2020-11-06       Impact factor: 3.411

Review 2.  The role of Sirtuin 1 in the pathophysiology of polycystic ovary syndrome.

Authors:  Mali Wu; Jie Zhang; Ran Gu; Fangfang Dai; Dongyong Yang; Yajing Zheng; Wei Tan; Yifan Jia; Bingshu Li; Yanxiang Cheng
Journal:  Eur J Med Res       Date:  2022-08-27       Impact factor: 4.981

Review 3.  Potential Role of Quercetin in Polycystic Ovary Syndrome and Its Complications: A Review.

Authors:  Tong Chen; Fan Jia; Yue Yu; Wufan Zhang; Chaoying Wang; Shiqin Zhu; Nana Zhang; Xinmin Liu
Journal:  Molecules       Date:  2022-07-13       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.